WHO ICTRP trial

An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety…

NL-OMON36798 · Overview of Medical Research in the Netherlands (NL-OMON)

Key facts

Trial ID NL-OMON36798
Public title An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 during Surgical Procedures in Patients with Haemophilia B
Scientific title An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 during Surgical Procedures in Patients with Haemophilia B - Paradigm3
Primary sponsor Novo Nordisk
Registry Overview of Medical Research in the Netherlands (NL-OMON)
Study type Interventional
Phase 3
Countries Canada;France;Germany;Hungary;Italy;Japan;Malaysia;Netherlands ;Republic of North Macedonia;Russian Federation ;South Africa;Sweden;Thailand;Turkey;United Kingdom;United States of America
Conditions blood clotting disorder Haemophilia B;10064477;blood clotting disorder;Haemophilia B
Interventions Weekly injections with N9-GP in the period prior to the surgery. An initial injection with N9-GP on the day of surgery, and afterwards depending on the patients needs. Besides, surgery related interventions. ;Haemophilia…
Registration date Feb 16, 2012
Target size 2
Secondary IDs 2010-023070-40;NCT01386528;NL35219.041.11
Registry page onderzoekmetmensen.nl

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations